Cargando…

Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia

Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) has become a major concern worldwide due to multidrug resistance and the ability to spread locally and globally. Infections caused by KPC-KP are great challenge in the healthcare systems because these are associated with longer hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubic, Zana, Jelic, Marko, Soprek, Silvija, Tarabene, Maja, Ujevic, Josip, Goic-Barisic, Ivana, Novak, Anita, Radic, Marina, Tambic Andrasevic, Arjana, Tonkic, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867991/
https://www.ncbi.nlm.nih.gov/pubmed/36683114
http://dx.doi.org/10.1007/s10123-023-00327-3
_version_ 1784876453513396224
author Rubic, Zana
Jelic, Marko
Soprek, Silvija
Tarabene, Maja
Ujevic, Josip
Goic-Barisic, Ivana
Novak, Anita
Radic, Marina
Tambic Andrasevic, Arjana
Tonkic, Marija
author_facet Rubic, Zana
Jelic, Marko
Soprek, Silvija
Tarabene, Maja
Ujevic, Josip
Goic-Barisic, Ivana
Novak, Anita
Radic, Marina
Tambic Andrasevic, Arjana
Tonkic, Marija
author_sort Rubic, Zana
collection PubMed
description Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) has become a major concern worldwide due to multidrug resistance and the ability to spread locally and globally. Infections caused by KPC-KP are great challenge in the healthcare systems because these are associated with longer hospitalization and high mortality. The emergence of colistin resistance has significantly reduced already limited treatment options. This study describes the molecular background of colistin-resistant KPC-KP isolates in the largest hospital in southern Croatia. Thirty-four non-duplicate colistin-resistant KPC-KP isolates were collected during routine work from April 2019 to January 2020 and from February to May 2021. Antimicrobial susceptibility was determined using disk diffusion, broth microdilution, and the gradient strip method. Carbapenemase was detected with an immunochromatographic test. Identification of bla(KPC) and mcr genes or mutations in pmrA, pmrB, mgrB, phoP, and phoQ genes were performed by polymerase chain reaction (PCR) and positive products were sequenced. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used for epidemiological analysis. All isolates were multidrug-resistant, with colistin minimum inhibitory concentrations (MICs) from 4 to >16 mg/L, and all harbored bla(KPC-2) and had a single point mutation in the mgrB gene resulting in a premature stop codon, with the exception of one isolate with four point mutations corresponding to stop codons. All isolates were negative for mcr genes. PFGE analysis identified a single genetic cluster, and MLST revealed that all isolates belonged to sequence type 101 (ST101). These results show emergence of the high-risk ST101/KPC-2 clone of K. pneumoniae in Croatia as well as appearance of colistin resistance due to mutations in the mgrB gene. Molecular analysis of epidemiology and possible resistance mechanisms are important to develop further strategies to combat such threats.
format Online
Article
Text
id pubmed-9867991
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98679912023-01-23 Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia Rubic, Zana Jelic, Marko Soprek, Silvija Tarabene, Maja Ujevic, Josip Goic-Barisic, Ivana Novak, Anita Radic, Marina Tambic Andrasevic, Arjana Tonkic, Marija Int Microbiol Research Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) has become a major concern worldwide due to multidrug resistance and the ability to spread locally and globally. Infections caused by KPC-KP are great challenge in the healthcare systems because these are associated with longer hospitalization and high mortality. The emergence of colistin resistance has significantly reduced already limited treatment options. This study describes the molecular background of colistin-resistant KPC-KP isolates in the largest hospital in southern Croatia. Thirty-four non-duplicate colistin-resistant KPC-KP isolates were collected during routine work from April 2019 to January 2020 and from February to May 2021. Antimicrobial susceptibility was determined using disk diffusion, broth microdilution, and the gradient strip method. Carbapenemase was detected with an immunochromatographic test. Identification of bla(KPC) and mcr genes or mutations in pmrA, pmrB, mgrB, phoP, and phoQ genes were performed by polymerase chain reaction (PCR) and positive products were sequenced. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used for epidemiological analysis. All isolates were multidrug-resistant, with colistin minimum inhibitory concentrations (MICs) from 4 to >16 mg/L, and all harbored bla(KPC-2) and had a single point mutation in the mgrB gene resulting in a premature stop codon, with the exception of one isolate with four point mutations corresponding to stop codons. All isolates were negative for mcr genes. PFGE analysis identified a single genetic cluster, and MLST revealed that all isolates belonged to sequence type 101 (ST101). These results show emergence of the high-risk ST101/KPC-2 clone of K. pneumoniae in Croatia as well as appearance of colistin resistance due to mutations in the mgrB gene. Molecular analysis of epidemiology and possible resistance mechanisms are important to develop further strategies to combat such threats. Springer International Publishing 2023-01-23 /pmc/articles/PMC9867991/ /pubmed/36683114 http://dx.doi.org/10.1007/s10123-023-00327-3 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research
Rubic, Zana
Jelic, Marko
Soprek, Silvija
Tarabene, Maja
Ujevic, Josip
Goic-Barisic, Ivana
Novak, Anita
Radic, Marina
Tambic Andrasevic, Arjana
Tonkic, Marija
Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title_full Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title_fullStr Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title_full_unstemmed Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title_short Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia
title_sort molecular characterization of colistin resistance genes in a high-risk st101/kpc-2 clone of klebsiella pneumoniae in a university hospital of split, croatia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867991/
https://www.ncbi.nlm.nih.gov/pubmed/36683114
http://dx.doi.org/10.1007/s10123-023-00327-3
work_keys_str_mv AT rubiczana molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT jelicmarko molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT sopreksilvija molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT tarabenemaja molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT ujevicjosip molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT goicbarisicivana molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT novakanita molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT radicmarina molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT tambicandrasevicarjana molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia
AT tonkicmarija molecularcharacterizationofcolistinresistancegenesinahighriskst101kpc2cloneofklebsiellapneumoniaeinauniversityhospitalofsplitcroatia